PATENT CLAIM ANALYSIS

Application Number: 16282199
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "269100"]

Abstract:
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.

Claim (Index 46):
The method of  claim 45 , wherein the at least one indication of neurological impairment is selected from the group consisting of impaired balance or coordination, motor impairment, loss of reflexes and self-preservation, long term neurocognitive injury and impairment, memory deficits, affective disorders, lack of hygiene-related behavior, convulsion, and fitting.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.2973
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15414925', '14529677', '15949472', '15773498', '15820943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.835674702449015
- 35 USC 102 Novelty (BERT): 0.6356804266904207
- Combined Prediction Score: 0.8156752748731555
- Mean Citation Score: 524.846092
- Max Citation Score: 677.586
- Similarity Product: 548.9682870576381

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test